Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "regulation of nuclear pre-mRNA domain containing 1A pseudogene" (LOC100130602, ENSG00000261835) is annotated as a processed pseudogene, a noncoding genomic segment bearing similarity to the protein-coding gene "regulation of nuclear pre-mRNA domain containing 1A". Pseudogenes such as this are typically non-functional remnants formed through retrotransposition or gene duplication and accumulate mutations that disrupt coding or promoter sequences[1][5]. While most processed pseudogenes do not produce proteins, some are transcribed at low levels and may regulate gene expression through mechanisms such as RNA interference or serving as microRNA decoys[5][6], but these roles are not established for LOC100130602. There are no reports implicating this pseudogene in human disease, therapeutic targeting, or pharmacological action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulation of nuclear pre-mRNA domain containing 1A pseudogene.